A Side by Side Comparison of Bruker Biotyper and VITEK MS: Utility of MALDI-TOF MS Technology for Microorganism Identification in a Public Health Reference Laboratory
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has emerged as a rapid, highly accurate, and cost-effective method for routine identification of a wide range of microorganisms. We carried out a side by side comparative evaluation of the performance of Bruker Biotyper versus VITEK MS for identification of a large and diverse collection of microorganisms. Most difficult and/or unusual microorganisms, as well as commonly encountered microorganisms were selected, including Gram-positive and negative bacteria, mycobacteria, actinomycetes, yeasts and filamentous fungi. Six hundred forty two strains representing 159 genera and 441 species from clinical specimens previously identified at the Laboratoire de santé publique du Québec (LSPQ) by reference methods were retrospectively chosen for the study. They included 254 Gram-positive bacteria, 167 Gram-negative bacteria, 109 mycobacteria and aerobic actinomycetes and 112 yeasts and moulds. MALDI-TOF MS analyses were performed on both systems according to the manufacturer's instructions. Of the 642 strains tested, the name of the genus and / or species of 572 strains were referenced in the Bruker database while 406 were present in the VITEK MS IVD database. The Biotyper correctly identified 494 (86.4%) of the strains, while the VITEK MS correctly identified 362 (92.3%) of the strains (excluding 14 mycobacteria that were not tested). Of the 70 strains not present in the Bruker database at the species level, the Biotyper correctly identified 10 (14.3%) to the genus level and 2 (2.9%) to the complex/group level. For 52 (74.2%) strains, we obtained no identification, and an incorrect identification was given for 6 (8.6%) strains. Of the 178 strains not present in the VITEK MS IVD database at the species level (excluding 71 untested mycobacteria and actinomycetes), the VITEK MS correctly identified 12 (6.8%) of the strains each to the genus and to the complex/group level. For 97 (54.5%) strains, no identification was given and for 69 (38.7%) strains, an incorrect identification was obtained. Our study demonstrates that both systems gave a high level (above 85%) of correct identification for a wide range of microorganisms. However, VITEK MS gave more misidentification when the microorganism analysed was not present in the database, compared to Bruker Biotyper. This should be taken into account when this technology is used alone for microorganism identification in a public health laboratory, where isolates received are often difficult to identify and/or unusual microorganisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, the clinically deployed use of wholeprotein MALDI-TOF MS for rapid identification of the species and strain of pathogenic bacteria has been adopted by thousands of hospitals and clinics worldwide 70,71 .”
From How many human proteoforms are there? (2018) · cites this paper as [71]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics
White, T. J., Bruns, T., Lee, S., & Taylor, J. (1990) · PCR Protocols · doi:10.1016/b978-0-12-372180-8.50042-1 · Cited by 36,648 · cited 1×
“All microorganisms were previously identified according to LSPQ reference methods: 16S rRNA [7] or tuf gene sequencing for Gram-positive bacteria, 16S rRNA, rpoB [8] or cpn60 gene [9] sequencing for Gramnegative bacteria, conventional biochemical testing for Enterobacteriaceae [10], 16S rRNA or hsp65 gene sequencing […”
MethodPCR protocols — A guide to methods and applications
U.G. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90252-7 · Cited by 11,702
Glass, N. L., & Donaldson, G. C. (1995) · Applied and Environmental Microbiology · doi:10.1128/aem.61.4.1323-1330.1995 · Cited by 4,755 · cited 1×
“All microorganisms were previously identified according to LSPQ reference methods: 16S rRNA [7] or tuf gene sequencing for Gram-positive bacteria, 16S rRNA, rpoB [8] or cpn60 gene [9] sequencing for Gramnegative bacteria, conventional biochemical testing for Enterobacteriaceae [10], 16S rRNA or hsp65 gene sequencing […”
MethodKurtzman, C. P., & Robnett, C. J. (1998) · Antonie van Leeuwenhoek · doi:10.1023/a:1001761008817 · Cited by 2,353 · cited 1×
“All microorganisms were previously identified according to LSPQ reference methods: 16S rRNA [7] or tuf gene sequencing for Gram-positive bacteria, 16S rRNA, rpoB [8] or cpn60 gene [9] sequencing for Gramnegative bacteria, conventional biochemical testing for Enterobacteriaceae [10], 16S rRNA or hsp65 gene sequencing […”
MethodPhylogeny, identification and nomenclature of the genus Aspergillus
Samson, R. A., Visagie, C. M., Houbraken, J., Hong, S.-B., Hubka, V., Klaassen, C. H. W., Perrone, G., Seifert, K. A., Susca, A., Tanney, J. B., et al. (2014) · Studies in Mycology · doi:10.1016/j.simyco.2014.07.004 · Cited by 1,136 · cited 1×
“All microorganisms were previously identified according to LSPQ reference methods: 16S rRNA [7] or tuf gene sequencing for Gram-positive bacteria, 16S rRNA, rpoB [8] or cpn60 gene [9] sequencing for Gramnegative bacteria, conventional biochemical testing for Enterobacteriaceae [10], 16S rRNA or hsp65 gene sequencing […”
MethodPCR protocols — A guide to methods and applications
SELIGER, H. (1990) · Trends in Biotechnology · doi:10.1016/0167-7799(90)90215-j · Cited by 1,062
Manual of Clinical Microbiology
(2011) · Wiley eBooks · doi:10.1128/9781555816728 · Cited by 1,003
Farmer, J. J., Davis, B. R., Hickman-Brenner, F. W., McWhorter, A., Huntley-Carter, G. P., Asbury, M. A., Riddle, C., Wathen-Grady, H. G., Elias, C., & Fanning, G. R. (1985) · Journal of Clinical Microbiology · doi:10.1128/jcm.21.1.46-76.1985 · Cited by 707
van Veen, S. Q., Claas, E. C. J., & Kuijper, E. J. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02071-09 · Cited by 667
Bizzini, A., Durussel, C., Bille, J., Greub, G., & Prod'hom, G. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01794-09 · Cited by 615
Research works printed but not linked: 4
- TC Dingle, 2013, Maldi-tof mass spectrometry for microorganism identification, Clin Lab Med, 33, 589, 10.1016/j.cll.2013.03.001 · DOI · Paper page
- TE McElvania, 2014, Evaluation of the Bruker Biotyper and VITEK MS MALDI-TOF MS systems for the identification of unusual and/or difficult-to-identify microorganisms isolated from clinical specimens, Eur J Clin Microbiol Infect Dis, 33, 2163, 10.1007/s10096-014-2183-y · DOI
- E Deak, 2015, Comparison of the Vitek MS and Bruker Microflex LT MALDI-TOF MS platforms for routine identification of commonly isolated bacteria and yeast in the clinical microbiology laboratory, Diagn Microbiol Infect Dis, 81, 27, 10.1016/j.diagmicrobio.2014.09.018 · DOI
- E Deak, 2015, Comparison of the Vitek MS and Bruker Microflex LT MALDI-TOF MS platforms for routine identification of commonly isolated bacteria and yeast in the clinical microbiology laboratory, Diagn Microbiol Infect Dis, 81, 27, 10.1016/j.diagmicrobio.2014.09.018 · DOI
Cited by
How many human proteoforms are there?
Aebersold, R., Agar, J. N., Amster, I. J., Baker, M. S., Bertozzi, C. R., Boja, E. S., Costello, C. E., Cravatt, B. F., Fenselau, C., Garcia, B. A., et al. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2576 · Cited by 907
Angeletti, S. (2017) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2016.09.003 · Cited by 247
“…method, Matrix Assisted Laser Desorption Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS), for the rapid identification of most pathogenic bacteria has been developed (Stevenson et al., 2010; Ferroni et al., 2010; Christner et al., 2010; Angeletti et al., 2015b; Levesque et al., 2015).”
MethodThe Human Proteoform Project: Defining the human proteome
Smith, L. M., Agar, J. N., Chamot-Rooke, J., Danis, P. O., Ge, Y., Loo, J. A., Paša-Tolić, L., Tsybin, Y. O., Kelleher, N. L., & The Consortium for Top-Down Proteomics (2021) · Science Advances · doi:10.1126/sciadv.abk0734 · Cited by 242
Tsuchida, S., Umemura, H., & Nakayama, T. (2020) · Molecules · doi:10.3390/molecules25204775 · Cited by 218
“Organisms for which percent probabilities < 60 are obtained should be considered unidentified [40].”
BackgroundA Moldy Application of MALDI: MALDI-ToF Mass Spectrometry for Fungal Identification
Patel, R. (2019) · Journal of Fungi · doi:10.3390/jof5010004 · Cited by 177
“They then created an in-house library, the Beijing Medical University database, using [11] strains of Mucor hiemalis, Mucor racemosus, Mucor irregularis, Cunninghamella phaeospora, Cunninghamella bertholletiae, and Cunninghamella echinulate.”
MethodTraditional and current-prospective methods of agricultural plant diseases detection: A review
Khakimov, A., Salakhutdinov, I., Omolikov, A., & Utaganov, S. (2022) · IOP Conference Series: Earth and Environmental Science · doi:10.1088/1755-1315/951/1/012002 · Cited by 165
Gajdács, M., Spengler, G., & Urbán, E. (2017) · Antibiotics · doi:10.3390/antibiotics6040025 · Cited by 169
“) [72,73], sequencing technologies are-in most cases-still in their developmental/experimental phase (and not necessarily well characterized for anaerobes) [29,62,74–76].”
BackgroundJang, K., & Kim, Y. H. (2018) · The Journal of Microbiology · doi:10.1007/s12275-018-7457-0 · Cited by 161
Sanguinetti, M., & Posteraro, B. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.01640-16 · Cited by 154
“When absent from their respective databases, 12 misidentifications (mainly to the genus level) were obtained with the Vitek MS system, as opposed to none with the Bruker Biotyper system (21).”
MethodRoberts, D. S., Loo, J. A., Tsybin, Y. O., Liu, X., Wu, S., Chamot-Rooke, J., Agar, J. N., Paša-Tolić, L., Smith, L. M., & Ge, Y. (2024) · Nature Reviews Methods Primers · doi:10.1038/s43586-024-00318-2 · Cited by 161
Oviaño, M., & Bou, G. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-18 · Cited by 161
Application and Perspectives of MALDI–TOF Mass Spectrometry in Clinical Microbiology Laboratories
Torres-Sangiao, E., Rodríguez, C. L., & García-Riestra, C. (2021) · Microorganisms · doi:10.3390/microorganisms9071539 · Cited by 159
“They also show high levels of identification at the species level (S ~85%) [18,51] with MALDI BioTyper being better suited for bacteria and yeast [51] and VITEK® MS (v3.”
MethodFlorio, W., Tavanti, A., Barnini, S., Ghelardi, E., & Lupetti, A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01097 · Cited by 134
Evaluation of Potential Probiotics Isolated from Human Milk and Colostrum
Damaceno, Q. S., Souza, J. P., Nicoli, J. R., Paula, R. L., Assis, G. B., Figueiredo, H. C. P., Azevedo, V., & Martins, F. S. (2017) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-017-9270-1 · Cited by 132
Normand, A., Cassagne, C., Gautier, M., Becker, P., Ranque, S., Hendrickx, M., & Piarroux, R. (2017) · BMC Microbiology · doi:10.1186/s12866-017-0937-2 · Cited by 115
Tsang, C., Tang, J. Y. M., Lau, S. K. P., & Woo, P. C. Y. (2018) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2018.05.003 · Cited by 119
“Given its numerous advantages, MALDI–TOF MS has been gaining popularity for identification of pathogenic microorganisms, including bacteria [108,109], yeasts [108–115] and even filamentous fungi [109,116–118], in clinical microbiology laboratories.”
BackgroundBocanegra‐Ibarias, P., Garza‐González, E., Morfín‐Otero, R., Barrios, H., Villarreal-Treviño, L., Rodríguez-Noriega, E., Garza–Ramos, U., Petersen-Morfín, S., & Silva-Sánchez, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179651 · Cited by 103
“Enterobacteriaceae species were identified by Matrix-Assisted Laser Desorption IonizationTime-of-Flight Mass Spectrometry (MALDI-TOF MS) using the Bruker Biotyper (Bruker Daltonics, Germany) as described previously [10].”
MethodLeung, L. M., Fondrie, W. E., Doi, Y., Johnson, J. K., Strickland, D. K., Ernst, R. K., & Goodlett, D. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-04793-4 · Cited by 94
Review of the impact of MALDI-TOF MS in public health and hospital hygiene, 2018
Rodríguez‐Sánchez, B., Cercenado, E., Coste, A. T., & Greub, G. (2019) · Eurosurveillance · doi:10.2807/1560-7917.es.2019.24.4.1800193 · Cited by 92
“Introduction During the past 10 years, Matrix Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) has changed microbiology routine practice by allowing timely and cost-effective identification of different microorganisms, not only from pure culture but also directly from clinical sampl…”
BackgroundTyping and Characterization of Bacteria Using Bottom-up Tandem Mass Spectrometry Proteomics
Boulund, F., Karlsson, R., Gonzales‐Siles, L., Johnning, A., Karami, N., AL-Bayati, O., Åhrén, C., Moore, E. R. B., & Kristiansson, E. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.061721 · Cited by 76
“tious diseases (5, 6), MS/MS-based techniques provide infor-”
BackgroundHuh, H. J., Kim, S., Jhun, B. W., Shin, S. J., & Koh, W. (2018) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2018.10.003 · Cited by 71
Cao, Y. W., Wang, L., Ma, P., Fan, W., Gu, B., & Ju, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-22642-w · Cited by 63
Liang, T., Leung, L. M., Opene, B. N. A., Fondrie, W. E., Lee, Y. I., Chandler, C. E., Yoon, S. H., Doi, Y., Ernst, R. K., & Goodlett, D. R. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b02611 · Cited by 63
Rapid Methods for Detection of MRSA in Clinical Specimens
Palavecino, E. L. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-664-1_3 · Cited by 59
Rapid Methods for Detection of MRSA in Clinical Specimens
Palavecino, E. L. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9849-4_2 · Cited by 51
MALDI-TOF MS – application in food microbiology
Akimowicz, M., & Bucka-Kolendo, J. (2020) · Acta Biochimica Polonica · doi:10.18388/abp.2020_5380 · Cited by 50
“…catalase and oxidase tests, analyzing gas production from glucose, microscopically evaluating the cell morphology and type of hemolysis, and conducting biochemical assays, such as tests for indole, urease, or aminopeptidase (Böhme et al., 2012; Soro-Yao et al., 2014; Lévesque et al., 2015).”
MethodInfluentialEl-Ashker, M. R., Gwida, M., Monecke, S., El-Gohary, F. A., Ehricht, R., Elsayed, M., Akinduti, P. A., El-Fateh, M., & Maurischat, S. (2019) · Veterinary Microbiology · doi:10.1016/j.vetmic.2019.108535 · Cited by 51
Mining the fecal proteome: from biomarkers to personalised medicine
Jin, P., Wang, K., Huang, C., & Nice, E. C. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1314786 · Cited by 49
“The traditional approaches have relied on cultivating microbes in the laboratory, isolating individual colonies and then studying these isolated strains to describe their phenotypic characteristics and metabolic capabilities [116,117].”
BackgroundLeyer, C., Gregorowicz, G., Mougari, F., Raskine, L., Cambau, E., & Briel, D. D. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00006-17 · Cited by 45
“Unlike the previous extraction procedure developed by the manufacturer (25), the tested protocol was safe as shown by the subsequent lack of growth of MTC species.”
MethodProteomics and the microbiome: pitfalls and potential
Lin, H., He, Q., Shi, L., Sleeman, M. W., Baker, M. S., & Nice, E. C. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1523724 · Cited by 47
“Interestingly, and perhaps somewhat surprisingly, rapid, accurate, and cost-effective clinical methods for routine identification of a wide range of microorganisms in the human microbiome, using commercial MALDI-TOF instruments such as the Bruker Biotyper or BioMerieux VITEK MS [104], were among the first MS methods t…”
BackgroundThe Basics and the Advancements in Diagnosis of Bacterial Lower Respiratory Tract Infections
Noviello, S., & Huang, D. B. (2019) · Diagnostics · doi:10.3390/diagnostics9020037 · Cited by 54
“In a study comparing the two systems, both systems correctly identified over 85% of the strains tested (254 Gram-positive bacteria, 167 Gram-negative bacteria, 109 mycobacteria and aerobic actinomycetes and 112 yeasts and mold), which included microorganisms associated with LRTIs [53].”
BackgroundSandalakis, V., Goniotakis, I., Vranakis, I., Chochlakis, D., & Psaroulaki, A. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1282825 · Cited by 41
Florio, W., Cappellini, S., Giordano, C., Vecchione, A., Ghelardi, E., & Lupetti, A. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1641-1 · Cited by 39
Isolation and Identification of Potential Probiotic Bacteria from Human Milk
Damaceno, Q. S., Gallotti, B., Reis, I. M. M., Totte, Y. C. P., Assis, G. B. N., Figueiredo, H. C. P., da Silva, T. F., Azevedo, V., Nicoli, J. R., & Martins, F. S. (2021) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-021-09866-5 · Cited by 40
Karger, A. (2016) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201600038 · Cited by 40
“Many studies report “orphan” spectra that could not be reliably assigned to any of the references in the database [93,94], partially for lack of appropriate references, but also because they result from new species [92].”
BackgroundMALDI-TOF MS identification and tracking of food spoilers and food-borne pathogens
de Koster, C. G., & Brul, S. (2016) · Current Opinion in Food Science · doi:10.1016/j.cofs.2016.11.004 · Cited by 36
“Molecular diagnostics rely mainly on separation of DNA restriction fragments and grouping of patterns thereof or sequencing of 16S ribosomal RNA, DNA sequencing or real-time PCR detection of target genes and MALDI-TOF MS detection of abundant cytosolic proteins [13,24].”
MethodPsaroulaki, A., & Chochlakis, D. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1499469 · Cited by 35
“Omic” Approaches to Bacteria and Antibiotic Resistance Identification
Janiszewska, D., Szultka‐Młyńska, M., Pomastowski, P., & Buszewski, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179601 · Cited by 37
A head-to-head comparison of three MALDI-TOF mass spectrometry systems with 16S rRNA gene sequencing
Dichtl, K., Klugherz, I., Greimel, H., Luxner, J., Köberl, J., Friedl, S., Steinmetz, I., & Leitner, E. (2023) · Journal of Clinical Microbiology · doi:10.1128/jcm.01913-22 · Cited by 33
Epperson, L. E., Timke, M., Hasan, N. A., Godo, P. G., Durbin, D., Helstrom, N. K., Shi, G., Kostrzewa, M., Strong, M., & Salfinger, M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03140 · Cited by 32
Recent applications of mass spectrometry in bacterial lipidomics
Appala, K., Bimpeh, K., Freeman, C. D., & Hines, K. M. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02541-8 · Cited by 34
Collaborative Antimicrobial Stewardship
Palavecino, E. L., Williamson, J., & Ohl, C. A. (2019) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2019.10.006 · Cited by 32
“The instruments have high performance characteristics and robust databases to identify the most common organisms isolated from clinical specimens.(14) Overall, identification is achieved 2 to 24 hours earlier for gram positives, and 24 to 72 hours earlier for gramnegative rods and yeasts compared with traditional syst…”
BackgroundIncidence of central venous catheter hub contamination
Holroyd, J. L., Vasilopoulos, T., Rice, M. J., Rand, K. H., & Fahy, B. G. (2017) · Journal of Critical Care · doi:10.1016/j.jcrc.2017.02.035 · Cited by 33
“Mass spectrometry has a reported accuracy of 90–100% on the genus level, and between 97–98% for Staphylococci and Streptococci; themost common organisms in this study [14,15].”
BackgroundMethodSun, Y., Guo, J., Chen, R., Hu, L., Xia, Q., Wu, W., Wang, J., & Hu, F. (2020) · Medical Mycology · doi:10.1093/mmy/myaa037 · Cited by 28
Prevalence and Characteristics of Bacillus cereus Group Isolated from Raw and Pasteurised Milk
Radmehr, B., Zaferanloo, B., Tran, T. B., Beale, D. J., & Palombo, E. A. (2020) · Current Microbiology · doi:10.1007/s00284-020-02129-6 · Cited by 27
Park, J. H., Jang, Y., Yoon, I., Kim, T. S., & Park, H. (2021) · BioMed Research International · doi:10.1155/2021/6667623 · Cited by 27
Ramzan, M., Raza, A., Nisa, Z. U., & Musharraf, S. G. (2022) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2022.104521 · Cited by 26
MALDI-TOF MS Is an Effective Technique To Classify Specific Microbiota
Chen, L., Gao, W., Tan, X., Han, Y., Fu, J., Feng, B., Xie, J., Li, B., Zhao, H., Tu, H., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00307-23 · Cited by 28
Luo, L., Cao, W., Chen, W., Zhang, R., Jing, L., Chen, H., Yu, F., & Yue, J. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0120-3 · Cited by 26
Yeasts Harbored by Vespine Wasps in the Pacific Northwest
Jimenez, S. I., Carroll, C. S., Babcock, T., Derstine, N. T., Hadwin, A. K. M., Moore, M. M., & Gries, G. (2016) · Environmental Entomology · doi:10.1093/ee/nvw173 · Cited by 25
“Using culturing, sequencing, and MALDI-TOF MS, a total of 27 representative cultivable microbial isolates were identified from the GI tract of five wasp species in the Pacific Northwest of North America.”
MethodInfluentialGutiérrez, C., Gómez-Flechoso, M. Á., Belda, I., Ruíz, J., Kayali, N., Polo, L. M., & Santos, A. (2017) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2017.05.003 · Cited by 26
Identification of pathogens from native urine samples by MALDI-TOF/TOF tandem mass spectrometry
Oros, D., Čeprnja, M., Žučko, J., Cindrić, M., Hozić, A., Škrlin, J., Barišić, K., Melvan, E., Uroić, K., Kos, B., et al. (2020) · Clinical Proteomics · doi:10.1186/s12014-020-09289-4 · Cited by 23
Rocca, M. F., Barrios, R., Zintgraff, J. C., Martínez, C., Irazú, L., Vay, C. A., & Prieto, M. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218077 · Cited by 22
Gao, W., Li, B., Ling, L., Zhang, L., & Yu, S. (2022) · Talanta · doi:10.1016/j.talanta.2022.123405 · Cited by 21
Dysregulation of Intestinal Microbiota Elicited by Food Allergy Induces IgA-Mediated Oral Dysbiosis
Matsui, S., Kataoka, H., Tanaka, J.-I., Kikuchi, M., Fukamachi, H., Morisaki, H., Matsushima, H., Mishima, K., Hironaka, S., Takaki, T., et al. (2019) · Infection and Immunity · doi:10.1128/iai.00741-19 · Cited by 21
“The spectra of the samples were analyzed using the Myla database to identify the species of origin (42).”
MethodCollis, R. M., Biggs, P. J., Burgess, S. A., Midwinter, A. C., Brightwell, G., & Cookson, A. L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.960748 · Cited by 25
“Isolates were identified by matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry (MS) (Bruker Daltonics, Billerica, CA, United States) using the previously described “on slide formic acid extraction” method (Lévesque et al., 2015).”
MethodHolland, R. D., Wilkes, J. G., Cooper, W. M., Alusta, P., Williams, A., Pearce, B. A., BEAUDOIN, M. A., & Buzatu, D. A. (2014) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.7060 · Cited by 21
Lutfullin, M. T., Lutfullina, G., Pudova, D. S., Akosah, Y. A., Shagimardanova, E. I., Vologin, S., Sharipova, M. R., & Mardanova, A. M. (2022) · 3 Biotech · doi:10.1007/s13205-022-03392-z · Cited by 21
Garza‐González, E., Bocanegra‐Ibarias, P., Rodríguez-Noriega, E., González-Díaz, E., Silva-Sánchez, J., Garza–Ramos, U., Contreras-Coronado-Tovar, I. F., Santos-Hernández, J. E., Gutiérrez-Bañuelos, D., Mena-Ramírez, J. P., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-05923-0 · Cited by 19
“Identification of isolates was confirmed by matrix-assisted laser desorption ionization time-of-flight mass spectrometry using the Bruker Biotyper system (Bruker Daltonics, Germany) as described previously [13].”
MethodPomerleau-Normandin, D., Heisz, M., & Su, M. (2018) · Canada Communicable Disease Report · doi:10.14745/ccdr.v44i05a04 · Cited by 19
“A number of studies have reported that misidentification of organisms by MALDI-TOF MS appeared to have been caused by the incompleteness of the reference libraries used (2,7-26).”
MethodThe Applications of MALDI-TOF MS in the Diagnosis of Microbiological Food Contamination
Kluz, M., Waszkiewicz‐Robak, B., & Kačániová, M. (2025) · Applied Sciences · doi:10.3390/app15147863 · Cited by 19
MALDI-TOF MS and Filamentous Fungal Identification: A Success Story?
Hendrickx, M. (2017) · Current Fungal Infection Reports · doi:10.1007/s12281-017-0277-6 · Cited by 18
Huang, Y., Zhang, M., Zhu, M., Wang, M., Sun, Y., Gu, H., Cao, J., Li, X., Zhang, S., Wang, J., et al. (2017) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-017-2297-3 · Cited by 17
Pathology, proteomics and the pathway to personalised medicine
Jin, P., Lan, J., Wang, K., Baker, M. S., Huang, C., & Nice, E. C. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1425618 · Cited by 19
“with a spectral library for data analysis [95].”
MethodEvaluation of the Autof MS1000 mass spectrometer in the identification of clinical isolates
Ma, Q., Zhang, Q., Yuan, Y., Yan, W., Wang, S., Xu, J., Zhang, J., Wang, Y., & Li, Y. (2020) · BMC Microbiology · doi:10.1186/s12866-020-02005-0 · Cited by 17
Burgess, S. A., Moinet, M., Brightwell, G., & Cookson, A. L. (2022) · Microbial Genomics · doi:10.1099/mgen.0.000893 · Cited by 17
Nualmalang, R., Thanomsridetchai, N., Teethaisong, Y., Sukphopetch, P., & Tangwattanachuleeporn, M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043191 · Cited by 17
“Due to MALDI-TOF MS being able to detect a variety of pathogens rapidly, it has extensively been employed to identify microorganisms, such as bacteria, yeasts and molds, from clinical samples routinely [15].”
MethodSiller, M., Hernández-Egido, S., Sánchez‐Juanes, F., González‐Buitrago, J. M., & Bellido, J. L. M. (2017) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2016.12.010 · Cited by 17
Liquid Extraction Surface Analysis Mass Spectrometry of ESKAPE Pathogens
Havlikova, J., May, R. C., Styles, I. B., & Cooper, H. J. (2021) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.0c00466 · Cited by 16
Sulaiman, I. M., Miranda, N., & Simpson, S. (2021) · Journal of AOAC International · doi:10.1093/jaoacint/qsab070 · Cited by 15
Application of MALDI-TOF MS for enumerating bacterial constituents of defined consortia
Coryell, M. P., Sava, R. L., Hastie, J. L., & Carlson, P. E. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12558-5 · Cited by 15
“While our study utilized only one MALDI-TOF MS instrument for MS-based colony identification, other instruments may perform at comparable levels (Pence et al. 2014; Levesque et al. 2015; Porte et al. 2017; Brown-Elliott et al. 2019; Park et al. 2021).”
MethodTuohy, J. M., Mueller‐Spitz, S. R., Albert, C. M., Scholz-Ng, S. E., Wall, M. E., Noutsios, G. T., Gutierrez, A. J., & Sandrin, T. R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02442 · Cited by 14
“, 2012) have become ubiquitous in many medical, clinical, and diagnostic labs (Lévesque et al., 2015).”
BackgroundFast methods of fungal and bacterial identification. MALDI-TOF mass spectrometry, chromogenic media
Siller‐Ruiz, M., Hernández-Egido, S., Sánchez‐Juanes, F., González‐Buitrago, J. M., & Bellido, J. L. M. (2017) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2017.03.016 · Cited by 13
Bajaj, A. O., Saraswat, S., Knuuttila, J. E. A., Freeke, J., Stielow, J. B., & Barker, A. P. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.656880 · Cited by 13
“Even MALDI-TOF, which has revolutionized the clinical microbiology identification of mycobacterium (Mather et al., 2014), could not discriminate MTBC species (particularly as IVD cleared test) (Chen et al., 2013; Lévesque et al., 2015).”
BackgroundManfredi, E., Rocca, M. F., Zintgraff, J. C., Irazú, L., Miliwebsky, E. S., Carbonari, C. C., Deza, N., Prieto, M. A., & Chinen, I. (2023) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001675 · Cited by 13
Chun, L. Y., Dolle-Molle, L., Bethel, C., Dimitroyannis, R. C., Williams, B. L., Schechet, S. A., Hariprasad, S. M., Missiakas, D. M., Schneewind, O., Beavis, K. G., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0227071 · Cited by 13
“Compared to traditional identification methods, MALDI-TOF MS holds high potential as an analytical tool for the characterization of different types of microorganisms, and has a gain of time of days[13,15,23].”
MethodJung, J. H., Kim, S.-Y., Park, Y.-J., Lee, J., Suk, H.-S., Ha, S. I., Shin, J. S., Park, K. G., & Kim, Y. (2020) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2020.08.004 · Cited by 13
Turvey, M. E., Weiland, F., Keller, E. J., & Hoffmann, P. (2017) · Journal of the Institute of Brewing · doi:10.1002/jib.428 · Cited by 12
Sulaiman, I. M., Hsieh, Y., & Simpson, S. (2019) · Journal of AOAC International · doi:10.5740/jaoacint.19-0170 · Cited by 12
Boonstra, M., Fouz, B., van Gelderen, B., Dalsgaard, I., Madsen, L., Jansson, E., Amaro, C., & Haenen, O. L. M. (2023) · Journal of Fish Diseases · doi:10.1111/jfd.13756 · Cited by 11
Hoyle, J. S., & Downard, K. M. (2023) · The Analyst · doi:10.1039/d3an00953j · Cited by 11
Burgess, S. A., Aplin, J., Biggs, P. J., Breckell, G. L., Benschop, J., Fayaz, A., Toombs-Ruane, L. J., & Midwinter, A. C. (2021) · International Dairy Journal · doi:10.1016/j.idairyj.2021.104998 · Cited by 11
Ransom, E. M., Wallace, M. A., Wiederhold, N. P., Cañete-Gibas, C. F., & Burnham, C. D. (2025) · Journal of Clinical Microbiology · doi:10.1128/jcm.01548-24 · Cited by 12
“This aggressive identification timeline is reflected in our overall lower identification rates compared to other reports (4, 5, 9, 36, 37).”
Wei, L., Shao, J., Song, Y., Wan, Z., Yao, L., Wang, H., & Yu, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.841286 · Cited by 10
Culturomics Approaches Expand the Diagnostic Accuracy for Sexually Transmitted Infections
Wolf, E. A., Rettig, H. C., Lupatsii, M., Schlüter, B., Schäfer, K., Friedrich, D., Graspeuntner, S., & Rupp, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910815 · Cited by 14
Froehlich, B. C., Popp, R., Sobsey, C. A., Ibrahim, S., LeBlanc, A. M., Mohammed, Y., Aguilar‐Mahecha, A., Poetz, O., Chen, M. X., Spatz, A., et al. (2020) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.202000034 · Cited by 9
Sharma, K., Angrup, A., Ghosh, A. K., Singh, S., Sood, A., Arora, A., Sharma, M., Sethi, S. K., Rudramurthy, S. M., Kaur, H., et al. (2024) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2024.116477 · Cited by 9
Mazhari, F., Regberg, A. B., Castro, C. L., & LaMontagne, M. G. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1499516 · Cited by 10
Du, Y., May, R. C., & Cooper, H. J. (2022) · Chemical Communications · doi:10.1039/d2cc02085h · Cited by 9
Hankins, J. D., Amerson-Brown, M. H., Brown, C. A., Riegler, A. N., Muldrew, K. L., & Dunn, J. J. (2023) · Future Microbiology · doi:10.2217/fmb-2023-0084 · Cited by 9
HILIC-IM-MS for Simultaneous Lipid and Metabolite Profiling of Bacteria
Carpenter, J. M., Hynds, H. M., Bimpeh, K., & Hines, K. M. (2023) · ACS Measurement Science Au · doi:10.1021/acsmeasuresciau.3c00051 · Cited by 9
Czeszewska-Rosiak, G., Złoch, M., Radosińska, M., Florkiewicz, A. B., Tretyn, A., & Pomastowski, P. (2024) · Archives of Microbiology · doi:10.1007/s00203-024-03885-w · Cited by 9
“Unfortunately, applying the genomic approach requires a well-trained operator with specialist knowledge and very accurate but complicated and expensive equipment (Lévesque et al. 2015; Nomura 2015; Soro-Yao et al. 2014).”
Evolving platforms for clinical mass spectrometry
Yang, J. Y., & Herold, D. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800871-3.00013-4 · Cited by 10
Tsuchida, S., Umemura, H., Murata, S., Miyabe, A., Satoh, M., Matsushita, K., Nakayama, T., & Nomura, F. (2021) · Journal of Chromatography B · doi:10.1016/j.jchromb.2021.122780 · Cited by 9
Oliveira, L. G., Silva, G. O. E., Barbosa, C. D., de Sant’Anna, F. M., de Castro, R. D., Figueiredo, N. C., Nunes, Á. C., Lage, A. P., & de Souza, M. R. (2018) · International Journal of Dairy Technology · doi:10.1111/1471-0307.12540 · Cited by 9
Litterio, M., Castello, L., Venuta, M. E., Abel, S., Canigia, L. F., Legaria, M. C., Rollet, R., Vaustat, D., Azula, N., Fox, B., et al. (2024) · Revista Argentina de Microbiología · doi:10.1016/j.ram.2023.12.001 · Cited by 8
Rodríguez-Noriega, E., Garza‐González, E., Bocanegra‐Ibarias, P., Paz-Velarde, B. A., Esparza-Ahumada, S., González-Díaz, E., Pérez-Gómez, H. R., Escobedo-Sánchez, R., León-Garnica, G., & Morfín‐Otero, R. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.867347 · Cited by 8
Chun, L. Y., Dahmer, D. J., Amin, S. V., Hariprasad, S. M., & Skondra, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911883 · Cited by 8
Non–C. difficileClostridioides Bacteremia in Intensive Care Patients, France
Morel, G., Mulier, G., Ghrenassia, E., Abdel-Nabey, M., Tandjaoui-Lambiotte, Y., Kouatchet, A., Platon, L., Pène, F., Moreau, A., Seguin, A., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2707.203471 · Cited by 8
“Global characteristics of patients with Clotristridium bacteremia, France* Characteristic Baseline population, n = 135 Survived, n -= 65 Died in ICU, n = 70 Age Age at diagnosis, median (IQR) 64 (51–75) 62 (50–70) 66 (54–79) Age at diagnostic >65 y 67 (50) 27 (42) 40 (57) Sex M 81 (60) 43 (66) 38 (54) F 54 (40) 22 (33…”
MethodFredua‐Agyeman, M., Ofosu‐Boateng, M., Offei, A. O., Mehta, M., Gaisford, S., & Limayem, A. (2020) · LWT · doi:10.1016/j.lwt.2020.109895 · Cited by 7
Metadata
- Authors
- Lévesque, S., Dufresne, P. J., Soualhine, H., Domingo, M.-C., Bekal, S., Lefebvre, B., & Tremblay, C.
- Affiliations
- Institut National de Santé Publique du Québec (CA)
- Corresponding author
- Lévesque, Simon
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-12-10
- Volume
- 10
- Issue
- 12
- Pages
- e0144878
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4689555
- OpenAlex
- W2209387386
- Cited by
- 172
- References
- 34
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 15 · 2023: 20 · 2022: 17 · 2021: 20 · 2020: 16 · 2019: 16 · 2018: 22 · 2017: 19 · 2016: 6
- FWCI
- 12.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Health Sciences › Medicine › Microbiology (medical) › Infections and bacterial resistance
- Keywords
- MALDI-TOF mass spectrometry, microbial identification, Bruker Biotyper, VITEK MS, method comparison, bacterial identification, mycobacteria, actinomycetes, molds and yeasts, Gram-positive bacteria, Gram-negative bacteria, reference laboratory, clinical isolates, identification accuracy, public health microbiology
- MeSH terms
- Fungi, Gram-Negative Bacteria, Humans, Mycobacterium, Public Health, Quebec, Yeasts, Reproducibility of Results, Bacterial Typing Techniques, Mycological Typing Techniques, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Clinical Laboratory Techniques, Actinobacteria, Clinical Laboratory Services
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.